Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial.
Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial. JAMA. 2003 Nov 05; 290(17):2284-91.
View in:
PubMed
subject areas
Adult
Aged
Angiography
Angioplasty, Balloon, Coronary
Contrast Media
Creatinine
Dopamine Agonists
Double-Blind Method
Female
Fenoldopam
Heart Diseases
Humans
Iodine Compounds
Kidney Diseases
Kidney Failure, Chronic
Male
Middle Aged
Prospective Studies
Vasodilator Agents
authors with profiles
Gary Schaer